Dermatology 


Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Principal Investigator: Amy Paller, MD
Contact:  Anne Mahoney, MD
Phone:  773-327-3326
E-mail: 

ClinicalTrials.gov Identifier: 
NCT00879944; IRB Number: 2009-13793


Open-label, Pilot study to Investigate the Safety and Tolerability of Alwextin 3.0% Cream in the Treatment of Epidermolysis Bullosa
Principal Investigator:
Amy Paller, MD
Contact: Amanda Silverio, MDPhone: (773) 327-9642
E-mail: 
C
ClinicalTrial.gov Identifier:  NCT00825565; IRB Number 2009-13625
 


Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy (HEMANGIOL)
Principal Investigator:Anthony J. Mancini, MD
Contact: Anne Mahoney, MD
Phone: (773) 327-3326
E-mail:
;   AMahoney@childrensmemorial.org
ClinicalTrials.gov Identifier:  NCT01056341; IRB Number 2010  


 Genetic Screening for Filaggrin mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Popluation
Principal Investigator:
Amy Paller, MD
Contact: Amanda Silverio, MD
Phone: (773) 327-9642
E-mail: 

ClinicalTrials.gov Identifier: NCT01016106;  IRB Number 2010-14049  


ADVN Biomarker Registry Study  
Condition: Atopic Dermatitis
Principal Investigator:
Amy Paller, MD 
Contact: Anne Mahoney,MD
Phone: 773-327-3326
Email:

ClinicalTrials.gov identifier: NCT00550316;  IRB Number: 2008-13500/13508
 


Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis (Genetics)
Principal Investigator:
Amy Paller, MD 
Contact: Anne Mahoney. MD
Phone: 773-327-3326
Email:

ClinicalTrials.gov identifier: NCT00515047

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris
Principal Investigator:
Amy Paller, MD
Contact: Amanda Silverio, MD
Phone: (773) 327-9642
E-mail: 

ClinicalTrials.gov Identifier:  NCT00817219 

Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
Principal Investigator:
Amy Paller, MD
Contact: Anne Mahoney, MD
Phone: (773) 327-3326
E-mail: 

ClinicalTrials.gov Identifier: NCT00311766;  IRB # 2006-12938
 

An Open-label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects with Plaque Psoriasis
Principal Investigator: Amy Paller, MD

Contact Person :  Amanda Silverio, MD

Phone number: 773-327-9642
 

Email:

ClinicalTrials.gov Identifier: NCT00141921  (IRB Number: 2005-12643)

Genetic Screening for Dermatologic Diseases
Principal Investigator: Amy Paller, MD

Contact Person:  Amanda Silverio, MD

Email:

Phone number: 773-327-9642
IRB Number: 2009-13803




A Pilot Study of reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation  (ALLOSCT) in Children with Recessive Dystrophic Epidermolysis Bullosa (RDEB) 
Principal Investigator: Amy Paller, MD

Contact Person: Anne Mahoney, MD

Email:
Phone number: 773-327-3326

IRB Number: 2009-13907
 


APPLES:  A Prospective Pediatric Longitudinal Evaluation to Assess the Long-term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis.  
Principal Investigator: Amy Paller, MD

Contact Person: Amanda Silverio, MD

Email:

Phone number: 773-327-9642

ClinicalTrials.gov Identifier: NCT00475605 (IRB Number: 2005-12622)
 


  

Childhood Atopic Dermatitis Impact Scale (CADIS)